{"name": "Welichem Biotech",
 "permalink": "welichem-biotech",
 "crunchbase_url": "http://www.crunchbase.com/company/welichem-biotech",
 "homepage_url": "http://www.welichem.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "",
 "description": "",
 "created_at": "Fri Jun 01 03:13:37 UTC 2012",
 "updated_at": "Fri Jun 01 03:14:32 UTC 2012",
 "overview": "\u003Cp\u003EWelichem Biotech Inc. is a publicly-traded biotechnology company developing therapeutic drugs in the fields of autoimmune diseases and cancers.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       31],
      "assets/images/resized/0019/3382/193382v1-max-150x150.jpg"],
     [[250,
       52],
      "assets/images/resized/0019/3382/193382v1-max-250x250.jpg"],
     [[331,
       70],
      "assets/images/resized/0019/3382/193382v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President \u0026 CEO",
    "person":
     {"first_name": "Liren",
      "last_name": "Tang",
      "permalink": "liren-tang",
      "image": null}},
   {"is_past": false,
    "title": "CSO",
    "person":
     {"first_name": "John",
      "last_name": "M. Webster",
      "permalink": "john-m-webster",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Harvey",
      "last_name": "S.K. Quan",
      "permalink": "harvey-s-k-quan",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "316-4475 Wayburne Drive",
    "address2": "",
    "zip_code": "V5G 3L1",
    "city": "Burnaby, BC",
    "state_code": null,
    "country_code": "CAN",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "GSK unit Stiefel snags rights to skin drug for CAD$35M",
    "stoned_year": 2012,
    "stoned_month": 5,
    "stoned_day": 31,
    "source_url": "http://www.fiercebiotech.com/story/gsk-unit-stiefel-snags-rights-skin-drug-cad35m/2012-05-31",
    "source_text": "",
    "source_description": "GSK unit Stiefel snags rights to skin drug for CAD$35M",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Welichem Biotech",
      "permalink": "welichem-biotech"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}